Vahdam India clocks ₹350-crore revenue, aims for ₹500 crore next year on global push
Homegrown wellness brand Vahdam India reported a strong FY26 performance, with revenue touching ₹350 crore, up 31% year on year (YoY), as deeper distribution in core markets and a push into high-margin supplements powered growth.
The company also posted its second consecutive year of profitability, even as it absorbed a sharp, albeit temporary, spike in US tariffs earlier in the year.
Founder Bala Sarda told Fortune India that the business closed the year at roughly ₹350 crore in revenue with about ₹8 crore in profit after tax (PAT). "Even though we had Trump tariffs, which was a significant outflow, we were profitable. Now that tariffs are back to zero, the business is fairly profitable on an adjusted basis as well," he said.
Looking ahead, the company is targeting ₹500 crore to ₹550 crore in revenue in FY27, with a clear focus on scaling its presence across North America and Europe while building a meaningful India business.
At present, North America and Canada contribute about 55% of revenue, followed by the UK and Europe at around 30%. India remains a small but fast-growing market, contributing 5% to 7%, a figure expected to rise to 15% to 20% over the next year.
Growth has been driven by a mix of online expansion and increasing offline presence in global markets. Nearly ₹70 crore, or about 19% of revenue, now comes from offline retail in the US alone, with products available through partners such as Walmart and Costco, and a national rollout in Target underway.
"Going deeper in our existing markets is a big trigger. The brand has been in place for a while and it's starting to compound," Sarda said.
Another key growth driver has been product innovation, particularly the expansion into functional herbal supplements. The company, known for its teas and infusions built on Indian botanicals like turmeric, ashwagandha and tulsi, is now offering these in formats such as capsules, effervescents and gummies.
The company expects about 30% of its FY27 revenue to come from this segment.
A third lever is India, where Vahdam has recently launched a tailored portfolio of teas, infusions and supplements. The business is already on track to reach a ₹100 crore run rate, growing roughly 1.5 times over last year.
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
